摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Poly(oxy-1,2-ethanediyl), I+/--[2-[[(dodecylthio)thioxomethyl]thio]-2-methyl-1-oxopropyl]-I-methoxy- | 710945-87-2

中文名称
——
中文别名
——
英文名称
Poly(oxy-1,2-ethanediyl), I+/--[2-[[(dodecylthio)thioxomethyl]thio]-2-methyl-1-oxopropyl]-I-methoxy-
英文别名
2-methoxyethyl 2-dodecylsulfanylcarbothioylsulfanyl-2-methylpropanoate
Poly(oxy-1,2-ethanediyl), I+/--[2-[[(dodecylthio)thioxomethyl]thio]-2-methyl-1-oxopropyl]-I-methoxy-化学式
CAS
710945-87-2
化学式
C20H38O3S3
mdl
——
分子量
422.7
InChiKey
POWFGZORDMVQGO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.1
  • 重原子数:
    26
  • 可旋转键数:
    19
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.9
  • 拓扑面积:
    118
  • 氢给体数:
    0
  • 氢受体数:
    6

文献信息

  • Polymeric prodrugs and subcutaneous and/or intramuscular administration thereof
    申请人:CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    公开号:US20200353090A1
    公开(公告)日:2020-11-12
    The invention relates to new prodrugs of active molecules. These prodrugs allow, in particular, the subcutaneous or intramuscular administration of active molecules of which the subcutaneous or intramuscular administration is problematic or impossible, in particular because of the toxicity at the injection site. The prodrugs according to the invention comprise an active ingredient, covalently linked with a polymer chain, preferably a hydrophilic and/or thermosensitive polymer chain. The invention relates, in particular, to polymeric prodrugs comprising a polymer chain formed at least in part by acrylamide monomer or one of its derivatives, the polymer comprising a proximal part and a terminal part; a first pharmaceutically active molecule covalently coupled to the proximal part of the polymer; possibly a second pharmaceutically active molecule covalently coupled to the terminal part of the polymer.
    该发明涉及新型活性分子的前药。这些前药允许特别是将活性分子皮下或肌肉内注射,而这些活性分子的皮下或肌肉内注射由于在注射部位的毒性而具有问题或不可能,特别是由于在注射部位的毒性。根据本发明的前药包括一种活性成分,与一根聚合物链共价连接,优选为一种亲性和/或热敏感性聚合物链。该发明特别涉及包括由丙烯酰胺单体或其衍生物之一至少部分形成的聚合物链的聚合物前药,该聚合物包括一个近端部分和一个末端部分;第一种药用活性分子共价结合到聚合物的近端部分;可能第二种药用活性分子共价结合到聚合物的末端部分。
  • Cross-linked impact modified polyphosphazenes
    申请人:INTERNATIONAL BUSINESS MACHINES CORPORATION
    公开号:US11059960B2
    公开(公告)日:2021-07-13
    A flame retardant composition and a method of making a flame retardant composition is provided. In an embodiment, the method includes reacting a phosphazene material with an acrylamide monomer material to form a functionalized phosphazene material; initiating a polymerization reaction on a reaction mixture comprising a functionalized phosphazene material and one or more monomers to form a first impact-modified phosphazene material; and reacting the first impact-modified phosphazene material with a poly(dichlorophosphazene) monomer material, and a reactant selected from the group consisting of R1OH, HNR2R3, or a combination thereof, to form a second impact-modified phosphazene material.
    本发明提供了一种阻燃组合物和一种阻燃组合物的制造方法。在一个实施方案中,该方法包括将化烯材料与丙烯酰胺单体材料反应,形成官能化化烯材料;在包含官能化化烯材料和一种或多种单体的反应混合物上引发聚合反应,形成第一抗冲改性化烯材料;将第一抗冲改性苯材料与聚(二苯)单体材料和选自 R1OH、HNR2R3 或其组合的反应物反应,形成第二抗冲改性苯材料。
  • THIOCARBONYLTHIO-FREE RAFT POLYMERS AND THE PROCESS OF MAKING THE SAME
    申请人:Henkel IP & Holding GmbH
    公开号:EP3334766A1
    公开(公告)日:2018-06-20
  • PRODROGUES POLYMÈRES ET LEUR ADMINISTRATION SOUS-CUTANEE ET/OU INTRAMUSCULAIRE
    申请人:Centre National de la Recherche Scientifique
    公开号:EP3710061A1
    公开(公告)日:2020-09-23
  • AMPHIPHILIC BLOCK COPOLYMER AND METHOD FOR PREPARING SAME
    申请人:Charleux Bernadette
    公开号:US20110207881A1
    公开(公告)日:2011-08-25
    The invention relates to an amphiphilic block copolymer, to the preparation thereof, and to the use thereof in the form of a self-stabilizing latex. The copolymer has the formula R 5 O—[—CH 2 CH 2 —O—] n —C(═O)—CR 3 R 4 —[CH 2 CR 6 R 7 ] m —S—C(═S)—S—R 1 where: R 1 is a straight or branched alkyl group, an alkenyl group having one or more —C═C— bonds, or an alkynyl group having one or more —C≡C— bonds, said groups including 8 to 18 carbon atoms; 20≦n≦100; R 3 and R 4 each are independently H, an alkyl group with 1 to 4 carbon atoms, or a nitrile group, at least one of R 3 and R 4 being different than H; R 6 is a phenyl group or an alkoxycarbonyl group in which the alkoxy group includes 1 to 8 carbon atoms; R 7 is a hydrogen atom or a methyl radical; and 20≦m≦1000. The preparation method comprises: preparing an aqueous solution of a compound R 1 —S—C(═S)—S—CR 3 R 4 —C(═O)—OR 2 in which R 2 is R 5 —[—O—CH 2 CH 2 —] n —, R 5 being a hydrophilic group and 20≦n≦100; adding to said solution one or more hydrophobic monomers of the formula (II) R 6 —CR 7 ═CH 2 and a free radical polymerisation initiator; and heating said aqueous solution to a temperature of 60-90° C.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸